During the recent session, Omega Healthcare Investors, Inc (NYSE:OHI)’s traded shares were 0.8 million, with the beta value of the company hitting 0.72. At the last check today, the stock’s price was $35.26, reflecting an intraday loss of -1.12% or -$0.4. The 52-week high for the OHI share is $44.42, that puts it down -25.98 from that peak though still a striking 13.56% gain since the share price plummeted to a 52-week low of $30.48. The company’s market capitalization is $10.20B, and the average trade volume was 2.53 million shares over the past three months.
Omega Healthcare Investors, Inc (OHI) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 2.35. OHI has a Sell rating from 0 analyst(s) out of 7 analysts who have looked at this stock. 3 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 4 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be 0.45.
Omega Healthcare Investors, Inc (NYSE:OHI) trade information
Omega Healthcare Investors, Inc (OHI) registered a -1.12% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -1.12% in intraday trading to $35.26, hitting a weekly high. The stock’s 5-day price performance is -8.56%, and it has moved by -2.62% in 30 days. Based on these gigs, the overall price performance for the year is 13.27%.
The consensus price target of analysts on Wall Street is $39, which implies an increase of 9.59% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $39 and $39 respectively. As a result, OHI is trading at a discount of -10.61% off the target high and -10.61% off the low.
Omega Healthcare Investors, Inc (OHI) estimates and forecasts
In the rating firms’ projections, revenue will increase 11.46% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 241.54M as predicted by 5 analyst(s). Meanwhile, a consensus of 5 analyst(s) estimates revenue growth to 245.54M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 210.4M and 227.77M respectively. In this case, analysts expect current quarter sales to grow by 14.80% and then jump by 7.80% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -0.44%. While earnings are projected to return 10.79% in 2025, the next five years will return 6.12% per annum.
OHI Dividends
Omega Healthcare Investors, Inc is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance. Investors should also take the other fundamental and operational aspects into account before investing in the stock. The forward dividend ratio for Omega Healthcare Investors, Inc is 3.35, with the dividend yield indicating at 9.50 percent, continuing the trend of increasing dividends in recent years.
The next largest institutional holding, with 30.1 million shares, is of BLACKROCK INC.’s that is approximately 12.0711% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $1.03 billion.
Also, the Mutual Funds coming in first place with the largest holdings of Omega Healthcare Investors, Inc (OHI) shares are VANGUARD SPECIALIZED FUNDS-Vanguard Real Estate Index Fund and iShares Trust-iShares Core S&P Mid-Cap ETF . Data provided on Jan 31, 2025 indicates that VANGUARD SPECIALIZED FUNDS-Vanguard Real Estate Index Fund owns about 9.95 shares. This amounts to just over 3.44 percent of the company’s overall shares, with a $352.02 million market value. The same data shows that the other fund manager holds slightly less at 9.21, or about 3.18% of the stock, which is worth about $325.69 million.
